MDT Stock Recent News

MDT LATEST HEADLINES

MDT Stock News Image - InvestorPlace

Undervalued healthcare stocks are primed for a comeback this year, proving themselves as lucrative investments amidst a revitalized market. With a significant uptick in performance, the S&P 500 Health Care index soared roughly 7% year-to-date (YTD), marking a robust recovery from last year's challenges.

InvestorPlace 2024 Mar 14
MDT Stock News Image - The Motley Fool

Medtronic is the world's largest medical device company, and it has a 46-year streak of consecutive annual dividend raises. Cigarette sales are steadily declining, but Altria Group's bottom line keeps on climbing.

The Motley Fool 2024 Mar 05
MDT Stock News Image - The Motley Fool

Dividend stocks are an excellent source of passive income. Some dividend payers are markedly safer investments than their peers, however.

The Motley Fool 2024 Feb 20
MDT Stock News Image - Zacks Investment Research

Medtronic (MDT) came out with quarterly earnings of $1.30 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.30 per share a year ago.

Zacks Investment Research 2024 Feb 20
MDT Stock News Image - InvestorPlace

Investing in dividend stocks is generally reserved for those who prefer steady returns and low volatility over the thrill of rapid potential gains. Investors saw tech stocks explode in 2023 as artificial intelligence emerged.

InvestorPlace 2024 Feb 06
MDT Stock News Image - InvestorPlace

Today's dividend stocks are increasingly popular in a wild reversal as top tech stocks take center stage and push market indices back to all-time highs. But that presents a prime opportunity for income investors and long-term “buy and hold” strategists.

InvestorPlace 2024 Jan 31
MDT Stock News Image - Zacks Investment Research

The latest trading day saw Medtronic (MDT) settling at $86.97, representing a -0.54% change from its previous close.

Zacks Investment Research 2024 Jan 30
MDT Stock News Image - The Motley Fool

Medtronic's global medical device business has supported annual dividend raises since 1978, and it's well positioned for more growth. AbbVie's lead drug fell off a patent cliff last year, but soaring sales of recently launched treatments make the stock a buy right now.

The Motley Fool 2024 Jan 28
MDT Stock News Image - InvestorPlace

2024 could easily turn into the year that value stocks come out on top. Though “official” numbers say differently, there's a clear sense of unease as tech-heavy indices soar to all-time highs despite wide-ranging layoffs pointing to troubled economic conditions.

InvestorPlace 2024 Jan 24
MDT Stock News Image - Seeking Alpha

We outline an Income Strategy for creating a self-sufficient portfolio for retirees and income-focused investors with $1 million to generate a life-long income stream. We explain the benefits of generating income through dividends and distributions rather than selling shares for capital gains. We compare the results of backtesting an income strategy with index investing for the past 24 years, starting from the year 2000.

Seeking Alpha 2024 Jan 13
10 of 50